Key Trends from the Association for Vascular Access’ Annual Scientific Meeting
By Medline Newsroom Staff | October 17, 2017
Ramzy Nasrallah, CEO for the Association for Vascular Access, sits down with Medline at AVA’s Annual Scientific Meeting to discuss the meeting’s highlights and the latest industry trends. A record breaking 915 clinical attendees were at the 2017 meeting. The crowd was eager for education and innovation in vascular access.
The CDC reports 250,000 central line associated blood stream infections occur each year.
“The trend is that historically peripheral IVs have been overlooked as the source of complication and infection, and what we’re starting to see with research and practice is that they’re now being seen as a threat to the patient’s condition,” said Ramzy Nasrallah, CEO of AVA.
AVA introduced the “Save That Line” campaign, which they promoted at their meeting. In addition to that campaign, AVA announced a new partnership with Medline to drive standardization and improve patient safety.
“What Medline does from our perspective is half technology, but also consulting the hospital to help them understand what they could be doing better and what gaps look like, and how Medline may be able to fill those gaps,” said Nasrallah. “Sometimes it’s not going to be a product solution. Sometimes it’s going to be a behavior change.”